about
Allopurinol: insights from studies of dose-response relationships.ABCG2 polymorphisms in gout: insights into disease susceptibility and treatment approachesThe association between gout and cataract risk: A meta-analysis.β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares.C5a Regulates IL-1β Production and Leukocyte Recruitment in a Murine Model of Monosodium Urate Crystal-Induced Peritonitis.Grape seed-derived procyanidins alleviate gout pain via NLRP3 inflammasome suppression.Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction.Current and future therapies for gout.Illness Perceptions and Mortality in Patients With Gout: A Prospective Observational Study.Management of Gout and Hyperuricemia in CKD.Baicalein decreases uric acid and prevents hyperuricemic nephropathy in mice.Lesinurad: A Review in Hyperuricaemia of Gout.Gout: An old disease in new perspective - A review.Risk of Febuxostat-Associated Myopathy in Patients with CKD.P2Y6 Receptor Antagonist MRS2578 Inhibits Neutrophil Activation and Aggregated Neutrophil Extracellular Trap Formation Induced by Gout-Associated Monosodium Urate Crystals.Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study.Anti-Gouty Arthritis and Antihyperuricemia Effects of Sunflower (Helianthus annuus) Head Extract in Gouty and Hyperuricemia Animal Models.DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A bindingTransglutaminase 2 in cartilage homoeostasis: novel links with inflammatory osteoarthritis.Rheumatology around the world: perspectives from Australia and New Zealand.Triggers of acute attacks of gout, does age of gout onset matter? A primary care based cross-sectional studyEffectiveness of an electronic patient-centred self-management tool for gout sufferers: a cluster randomised controlled trail protocolCD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis.PPARGC1B: insight into the expression of the gouty inflammation phenotype: PPARGC1B and gouty inflammation.Designing a mutant Candida uricase with improved polymerization state and enzymatic activity.Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations."What say ye gout experts?" a content analysis of questions about gout posted on the social news website Reddit.Increased platelet reactivity as measured by plasma glycoprotein VI in gout.Inflammation in gout: mechanisms and therapeutic targets.Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout.Allopurinol and peripheral vascular disease: enough observational data to warrant interventional studies: Allopurinol and the prevention of vascular disease.Gout in a rheumatology clinic: results of EULAR/ACR guidelines-compliant treatment.Successful febuxostat desensitization in a patient with febuxostat hypersensitivity: A Malaysian experience.Population-Specific Resequencing Associates the ATP-Binding Cassette Subfamily C Member 4 Gene With Gout in New Zealand Māori and Pacific Men.Soluble uric acid increases PDZK1 and ABCG2 expression in human intestinal cell lines via the TLR4-NLRP3 inflammasome and PI3K/Akt signaling pathway.Imaging tools to measure treatment response in gout.Novel uricosurics.Cardiac and renal protective effects of urate-lowering therapy.Treatment of gout: where are we now?The management of hyperuricemia: back to the pathophysiology of uric acid.
P2860
Q30240163-E3A44AFD-ED96-467C-96AD-C106083D4EB4Q33602553-B9BFA4D6-AC39-4BFE-986E-31901C851C9AQ33853427-CA83E434-3982-4B96-A880-D0CFF0AFAED8Q36294205-9D23DA94-EB3F-4192-8AEC-113E2A778473Q37597916-9D986DE9-9A31-4A24-8C94-9721FC282A61Q37737949-5A210DF1-FDB2-4D01-960A-5E5DC5E609F5Q38654549-3DB41994-8469-48A6-A585-46D716614633Q38660829-D435E833-87B3-487C-9183-6FDED3F8E169Q38798592-03A72FDD-A089-44B2-87E3-B7E130710F3EQ38812962-5FC848EB-5261-4A73-B6B7-82B10A0FDB95Q38818748-8C0EE6C0-6B72-41A8-864B-B2451A8D4E62Q39251437-A07274A5-DCF5-42AB-8F4E-96DC2F4F624AQ40106739-78592B54-414E-4EFC-95BF-898DB04D5327Q40288477-F3C0A19F-BC15-4CD2-894F-D7420066167EQ40428922-989CA598-A6C1-41A1-966B-2A298162E571Q41086087-6368BD98-236B-4B24-8856-659BFEF2AD56Q41448685-3176021D-793F-447B-9B10-E48042930BF0Q41712674-7DE1D11F-E34A-41E9-935B-32018A3352BDQ42318954-034E752B-EDF5-431A-8E5E-97640EE892C7Q42322540-9D4D9363-E62D-4DCC-B7E2-96863880D758Q42375723-2DFC0A2E-1818-44CA-8AA8-DE3F4594CD69Q42650070-0BC82193-6AA6-490A-BD73-961FC788D185Q44412481-207D9BD0-A60B-4444-B085-0C8DB112EC99Q46234455-A0E2362D-207E-4DAF-8FCF-47CDAFC61363Q46257023-988DA3E5-47CB-4F17-B348-1002C83F073EQ47104100-F3A5E7D7-E07A-4998-8BBC-EBCA44C8EEC6Q47423223-01392290-3A52-4CAC-9508-76567847EA1DQ47678335-46E03ACF-3C2C-4F88-BB0E-FEC0027296B2Q47729156-6B7DC993-F3FF-46B4-B9CE-777811683F39Q47731199-3F24532F-7A06-4C24-AF3E-E3163695A29DQ47883251-31886EB4-3029-4665-84B3-0A6069119DB7Q48004929-B41BA223-4D4C-408E-9CE9-0BB2CA42CEC4Q48275640-BB9166B9-4DF4-4CFE-8B98-860C59D0C566Q48524891-D2762342-9932-41E8-85BF-7EC3D2688234Q49258083-8B3DF1E2-E747-412B-A776-517E48885D79Q49616051-0C875179-03F8-427F-A96F-9F5E9101751BQ49616067-5D9E21CA-F9E5-46FA-AB10-12CCA521F442Q49616077-97E10C62-CD7B-4388-8C3A-7FCA5F0854F7Q49616087-6380E7D6-D9DD-4629-B7CD-CEEB52C168CCQ49793170-8F6D71F6-35C2-4ADA-BCFE-35E3237AFF50
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Gout.
@ast
Gout.
@en
type
label
Gout.
@ast
Gout.
@en
prefLabel
Gout.
@ast
Gout.
@en
P1433
P1476
Gout.
@en
P2093
Lisa K Stamp
P304
P356
10.1016/S0140-6736(16)00346-9
P407
P577
2016-04-21T00:00:00Z